+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Paclitaxel Coated Balloon Catheter Market - Global Forecast 2026-2032- Product Image
Paclitaxel Coated Balloon Catheter Market - Global Forecast 2026-2032- Product Image
Sale

Paclitaxel Coated Balloon Catheter Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6138973
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Paclitaxel Coated Balloon Catheter Market is projected to reach USD 322.62 Million in 2026. It is expected to continue growing at a CAGR of 5.98%, reaching USD 456.72 Million by 2032.

Paclitaxel-Coated Balloon Catheters: Clinical Role and Market Context

Paclitaxel-coated balloon catheters are used to deliver an antiproliferative drug to the vessel wall during angioplasty, with the aim of limiting neointimal hyperplasia and reducing restenosis. Their principal applications are in peripheral and coronary interventions, although clinical use depends on anatomy, lesion characteristics, device labeling, operator judgment, and applicable guidance. The technology is relevant where treatment seeks to avoid or reduce permanent implants, but outcomes must be assessed against alternative drug-eluting and uncoated devices in the specific clinical setting.

Clinical Evidence, Regulation, and Procedure Design Are Reshaping Adoption

The landscape is being shaped by evolving evidence on mortality, restenosis, patency, thrombosis, and repeat intervention, as well as by differences between peripheral and coronary use. Regulators and clinical societies have emphasized careful interpretation of safety signals, transparent trial design, appropriate comparators, and long-term follow-up. Adoption is also influenced by catheter deliverability, lesion preparation, drug transfer, inflation time, bailout stenting requirements, reimbursement, and the availability of trained interventional teams.

Artificial Intelligence Is Strengthening Selection, Planning, and Evidence Generation

Artificial intelligence can support imaging analysis, lesion classification, procedural planning, and identification of patients at elevated risk of restenosis or complications. Machine-learning tools may help integrate angiography, intravascular imaging, clinical history, and longitudinal outcomes, while automation can improve consistency in device and lesion documentation. These benefits remain dependent on representative datasets, external validation, clinician oversight, cybersecurity, and compliance with medical-device software requirements; AI does not replace randomized evidence or professional judgment.

Regional Insights: Access and Evidence Requirements Differ Across Care Systems

North America combines advanced interventional infrastructure with rigorous regulatory, reimbursement, and post-market evidence expectations. Europe emphasizes conformity assessment, clinical evaluation, and health-system value, while national procurement and reimbursement practices remain important. Asia-Pacific includes sophisticated cardiovascular centers alongside fast-expanding access gaps, making training, affordability, and local evidence material. Latin America is influenced by imported-device dependence, uneven reimbursement, and concentration of specialist care. The Middle East is supported by tertiary hospitals and investment in advanced procedures, but access varies by country. Africa faces greater constraints in catheterization capacity, specialist availability, supply continuity, and follow-up, increasing the importance of appropriate patient selection and durable training programs.

Group Insights: Economic Blocs and Alliances Shape Procurement and Standards

ASEAN markets differ substantially in regulatory maturity, reimbursement, and interventional capacity, creating a need for adaptable registration and training approaches. BRICS members span large and diverse healthcare systems, with domestic manufacturing, affordability, and uneven access influencing device pathways. The European Union benefits from shared regulatory structures but retains national differences in assessment and purchasing. G7 systems generally demand robust clinical evidence, safety monitoring, and health-economic justification. GCC countries often have well-equipped tertiary centers and centralized procurement, while NATO members represent a broad set of healthcare systems where resilient supply chains and standardized clinical governance can support continuity of care.

Country Insights: National Evidence, Reimbursement, and Capacity Remain Decisive

Australia and Canada require alignment with national regulatory and reimbursement processes across geographically dispersed care networks. Brazil and Mexico face regional disparities in specialist access and public-private differences, making training and supply reliability important. China and India combine substantial clinical need with varied hospital capability, local regulatory requirements, and growing interest in evidence generation and manufacturing. Japan, South Korea, Singapore, and Australia generally have advanced procedural environments, although reimbursement and clinical adoption criteria differ. France, Germany, Italy, Spain, and the United Kingdom evaluate the technology through distinct national or regional pathways involving clinical evidence, procurement, and cost considerations. Russia’s access is affected by regulatory, supply-chain, and healthcare-system conditions. In the United States, adoption is closely tied to regulatory status, guideline interpretation, payer policy, procedural evidence, and post-market surveillance.

Actionable Priorities for Leaders: Prove Value, Control Risk, and Improve Access

Industry leaders should prioritize well-designed comparative studies with clinically meaningful endpoints, transparent long-term follow-up, and clear separation of coronary and peripheral indications. They should strengthen pharmacovigilance, standardized device tracking, and real-world evidence without overstating observational findings. Product development should focus on predictable drug transfer, navigability, lesion preparation, and compatibility with imaging and bailout strategies. Market access plans should address country-specific reimbursement and procurement requirements, while education programs should emphasize patient selection, inflation technique, contraindication management, and complication response. Responsible AI deployment should include bias testing, explainability, human oversight, and secure integration into clinical workflows.

Research Methodology: Triangulating Clinical, Regulatory, and Health-System Evidence

This executive summary uses a structured review of the technology’s clinical function, procedure-specific evidence themes, regulatory considerations, healthcare-system conditions, and regional access factors. Interpretation should distinguish established findings from areas requiring further validation and should account for differences in lesion type, vascular bed, comparator, follow-up duration, and endpoint definition. Regional, group, and country observations are framed qualitatively around documented healthcare capacity, regulatory structure, reimbursement, procurement, and treatment access. No market estimates, market shares, forecasts, or company-specific claims are used.

Conclusion: Sustainable Use Depends on Evidence-Based Integration

Paclitaxel-coated balloon catheters occupy a clinically important role where drug delivery without routine permanent implantation may be appropriate, but their value is indication- and patient-dependent. Durable progress will require credible comparative evidence, careful safety monitoring, skilled procedural execution, and reimbursement aligned with demonstrated outcomes. Differences across regions, economic groups, and countries mean that adoption strategies must combine clinical rigor with practical attention to training, affordability, supply continuity, and equitable access.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Paclitaxel Coated Balloon Catheter Market, by Indication
7.1. Introduction
7.2. Coronary Artery Disease
7.3. In-Stent Restenosis
7.4. Peripheral Arterial Disease
8. Paclitaxel Coated Balloon Catheter Market, by Product Type
8.1. Introduction
8.2. Double Layer Coating
8.3. Single Layer Coating
9. Paclitaxel Coated Balloon Catheter Market, by Balloon Compliance
9.1. Introduction
9.2. Non Compliant
9.3. Semi Compliant
10. Paclitaxel Coated Balloon Catheter Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Center
10.3. Cardiac Catheterization Lab
10.4. Hospitals
11. Paclitaxel Coated Balloon Catheter Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Paclitaxel Coated Balloon Catheter Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Paclitaxel Coated Balloon Catheter Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Acotec Scientific Co Ltd
15.3. AR Baltic Medical
15.4. B. Braun Melsungen AG
15.5. Becton Dickinson and Company
15.6. Beijing Lepu Medical Technology Co Ltd
15.7. BIOTRONIK SE & Co KG
15.8. Boston Scientific Corporation
15.9. Cardionovum
15.10. Cook Medical LLC
15.11. eucatech AG
15.12. Eurocor Tech GmbH
15.13. Hangzhou APT Medical Co Ltd
15.14. iVascular S.L.U.
15.15. Medtronic plc
15.16. MicroPort Scientific Corporation
15.17. OrbusNeich Medical B.V.
15.18. Shenzhen Sinomed Medical Device Co Ltd.
15.19. Zhejiang Barty Medical Technology
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Paclitaxel Coated Balloon Catheter Market, Years Considered for the Study
FIGURE 2. Global Paclitaxel Coated Balloon Catheter Market, Research Design
FIGURE 3. Global Paclitaxel Coated Balloon Catheter Market, Research Framework
FIGURE 4. Global Paclitaxel Coated Balloon Catheter Market, Data Triangulation
FIGURE 5. Global Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 7. Global Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2025 vs 2032 (%)
FIGURE 11. Global Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Paclitaxel Coated Balloon Catheter Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Paclitaxel Coated Balloon Catheter Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Paclitaxel Coated Balloon Catheter Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Paclitaxel Coated Balloon Catheter Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Paclitaxel Coated Balloon Catheter Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Paclitaxel Coated Balloon Catheter Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Paclitaxel Coated Balloon Catheter Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Paclitaxel Coated Balloon Catheter Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Paclitaxel Coated Balloon Catheter Market Segmentation & Coverage
TABLE 2. Global Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
TABLE 3. Global Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 4. Global Coronary Artery Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Coronary Artery Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Coronary Artery Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global In-Stent Restenosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global In-Stent Restenosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global In-Stent Restenosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Peripheral Arterial Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Peripheral Arterial Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Peripheral Arterial Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 14. Global Double Layer Coating Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Double Layer Coating Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Double Layer Coating Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Single Layer Coating Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Single Layer Coating Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Single Layer Coating Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 21. Global Non Compliant Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Non Compliant Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Non Compliant Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Semi Compliant Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Semi Compliant Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Semi Compliant Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 28. Global Ambulatory Surgical Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Ambulatory Surgical Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Ambulatory Surgical Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Cardiac Catheterization Lab Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Cardiac Catheterization Lab Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Cardiac Catheterization Lab Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Paclitaxel Coated Balloon Catheter Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Asia-Pacific Paclitaxel Coated Balloon Catheter Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Asia-Pacific Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 40. Asia-Pacific Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 41. Asia-Pacific Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 42. Asia-Pacific Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 43. North America Paclitaxel Coated Balloon Catheter Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. North America Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 45. North America Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 46. North America Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 47. North America Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 48. Latin America Paclitaxel Coated Balloon Catheter Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Latin America Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 50. Latin America Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 51. Latin America Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 52. Latin America Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 53. Europe Paclitaxel Coated Balloon Catheter Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Europe Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 55. Europe Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 56. Europe Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 57. Europe Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 58. Middle East Paclitaxel Coated Balloon Catheter Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Middle East Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 60. Middle East Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 61. Middle East Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 62. Middle East Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 63. Africa Paclitaxel Coated Balloon Catheter Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Africa Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 65. Africa Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 66. Africa Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 67. Africa Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. Global Paclitaxel Coated Balloon Catheter Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. ASEAN Paclitaxel Coated Balloon Catheter Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. ASEAN Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 71. ASEAN Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 72. ASEAN Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 73. ASEAN Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 74. GCC Paclitaxel Coated Balloon Catheter Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. GCC Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 76. GCC Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 77. GCC Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 78. GCC Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. European Union Paclitaxel Coated Balloon Catheter Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. European Union Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 81. European Union Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 82. European Union Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 83. European Union Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. BRICS Paclitaxel Coated Balloon Catheter Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. BRICS Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 86. BRICS Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 87. BRICS Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 88. BRICS Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. G7 Paclitaxel Coated Balloon Catheter Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. G7 Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 91. G7 Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 92. G7 Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 93. G7 Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. NATO Paclitaxel Coated Balloon Catheter Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. NATO Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 96. NATO Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. NATO Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 98. NATO Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Global Paclitaxel Coated Balloon Catheter Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. United States Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
TABLE 101. United States Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 102. United States Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 103. United States Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 104. United States Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Canada Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
TABLE 106. Canada Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 107. Canada Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. Canada Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 109. Canada Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. Mexico Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
TABLE 111. Mexico Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 112. Mexico Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. Mexico Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 114. Mexico Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. Brazil Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
TABLE 116. Brazil Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 117. Brazil Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 118. Brazil Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 119. Brazil Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. United Kingdom Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
TABLE 121. United Kingdom Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 122. United Kingdom Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 123. United Kingdom Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 124. United Kingdom Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. Germany Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
TABLE 126. Germany Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 127. Germany Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 128. Germany Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 129. Germany Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. France Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
TABLE 131. France Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 132. France Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. France Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 134. France Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. Russia Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
TABLE 136. Russia Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 137. Russia Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 138. Russia Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 139. Russia Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. Italy Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
TABLE 141. Italy Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 142. Italy Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. Italy Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 144. Italy Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Spain Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
TABLE 146. Spain Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 147. Spain Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. Spain Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 149. Spain Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. China Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
TABLE 151. China Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 152. China Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 153. China Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 154. China Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. India Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
TABLE 156. India Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 157. India Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 158. India Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 159. India Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. Japan Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
TABLE 161. Japan Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 162. Japan Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. Japan Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 164. Japan Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Australia Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
TABLE 166. Australia Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 167. Australia Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. Australia Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 169. Australia Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. South Korea Paclitaxel Coated Balloon Catheter Market Size, 2017-2032 (USD Million)
TABLE 171. South Korea Paclitaxel Coated Balloon Catheter Market Size, by Indication, 2017-2032 (USD Million)
TABLE 172. South Korea Paclitaxel Coated Balloon Catheter Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 173. South Korea Paclitaxel Coated Balloon Catheter Market Size, by Balloon Compliance, 2017-2032 (USD Million)
TABLE 174. South Korea Paclitaxel Coated Balloon Catheter Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Global Paclitaxel Coated Balloon Catheter Market Share, by Key Player, 2025
TABLE 176. Global Paclitaxel Coated Balloon Catheter Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Acotec Scientific Co Ltd
  • AR Baltic Medical
  • B. Braun Melsungen AG
  • Becton Dickinson and Company
  • Beijing Lepu Medical Technology Co Ltd
  • BIOTRONIK SE & Co KG
  • Boston Scientific Corporation
  • Cardionovum
  • Cook Medical LLC
  • eucatech AG
  • Eurocor Tech GmbH
  • Hangzhou APT Medical Co Ltd
  • iVascular S.L.U.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • OrbusNeich Medical B.V.
  • Shenzhen Sinomed Medical Device Co Ltd.
  • Zhejiang Barty Medical Technology

Related Topics

Related Reports

Drug-Coated Balloon Catheters - Global Strategic Business Report - Product Image

Drug-Coated Balloon Catheters - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
PTA Balloon Catheter Market - Global Forecast 2026-2032 - Product Image

PTA Balloon Catheter Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Drug-coated Balloon Catheter Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Drug-coated Balloon Catheter Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Coronary Balloon Catheters Market - Global Forecast 2026-2032 - Product Image

Coronary Balloon Catheters Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Global PTA Balloon Catheter - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Global PTA Balloon Catheter - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 111 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.